MedTrace Logo

Study In Patients With Dyslipidaemia

NCT00264667 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 290

Last updated 2016-10-28

No results posted yet for this study

Summary

Study in patients with dyslipidaemia.

Conditions

  • Metabolic Syndrome X

Interventions

DRUG

GW677954

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Completion
2007-06-30

Countries

  • Argentina
  • Australia
  • Chile
  • Costa Rica
  • India
  • Latvia
  • Mexico
  • New Zealand
  • Pakistan
  • Romania
  • Russia
  • Slovakia
  • Spain

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00264667 on ClinicalTrials.gov